Back to Search
ROBERT FRAM, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1740323146Individual
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
44156(MA)
Research & Publications (18)
A perspective on errors, bias, and interpretation in the forensic sciences and direction for continuing advancement.
PMID 19486241·J Forensic Sci·2009
8-other
Insulin resistance, secretion and breakdown are increased 9 months following severe burn injury.
PMID 18672331·Burns·2009
8-other
XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer.
PMID 19682517·Adv Drug Deliv Rev·2009
4-observational
Human mitochondrial oxidative capacity is acutely impaired after burn trauma.
PMID 18639661·Am J Surg·2008
8-other
Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate.
PMID 17245174·Ann Surg·2007
2-rct
Recovery of labeled CO2 from acetate in severely burned children.
PMID 17895286·Am J Physiol Endocrinol Metab·2007
8-other
PPAR-alpha agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial.
PMID 17451602·Nutr Metab (Lond)·2007
8-other
A phase I study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously daily for 5 consecutive days every 3 weeks in patients with advanced solid tumors.
PMID 16278403·Clin Cancer Res·2005
3-trial
A clinically relevant SCID-hu in vivo model of human multiple myeloma.
PMID 15817674·Blood·2005
7-preclinical
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
PMID 15940263·Oncogene·2005
8-other
Serum creatinine kinase levels for diagnosing muscle damage in electrical burns.
PMID 15993317·Burns·2005
8-other
Phase I and pharmacokinetic study of the dolastatin-15 analogue tasidotin (ILX651) administered intravenously on days 1, 3, and 5 every 3 weeks in patients with advanced solid tumors.
PMID 16278405·Clin Cancer Res·2005
3-trial
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis.
PMID 11830534·Cancer Res·2002
7-preclinical
Glucan phosphate potentiates endotoxin-induced interferon-gamma expression in immunocompetent mice, but attenuates induction of endotoxin tolerance.
PMID 11724637·Clin Sci (Lond)·2001
7-preclinical
Phase I and pharmacokinetic study of LU79553, a DNA intercalating bisnaphthalimide, in patients with solid malignancies.
PMID 11157040·J Clin Oncol·2001
3-trial
A phase I clinical and pharmacokinetic study of the dolastatin analogue cemadotin administered as a 5-day continuous intravenous infusion.
PMID 11052630·Cancer Chemother Pharmacol·2000
3-trial
Hypercalcemia and T-cell lymphoma with acquired immunodeficiency syndrome: occurrence without human T-cell leukemia virus-I.
PMID 11005350·South Med J·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- IMMUNOGEN, INC., 128 SIDNEY ST
CAMBRIDGE, MA 02138 - Phone
- (617) 995-4909
Quick Facts
- NPI
- 1740323146
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile